The Accelerating Medicines Partnership (AMP®) program is a public-private partnership between the National Institutes of Health the U.S. Food and Drug Administration the European Medicines Agency pharmaceutical and life science companies non-profit and other organizations. The AMP Schizophrenia (SCZ) program was launched in 2020 to address the critical need for more effective treatments for people with schizophrenia and related mental health conditions. To date the program has enrolled nearly 1000 participants from over 40 sites around the world. This session will share how early findings from the study can already be used to inform the clinical care of people at high clinical risk of developing psychosis. Focusing first on an overview of this study the next topic will be a review of smartphone monitoring used in the research and insights into how changes in sleep and suicidal thoughts can be captured digitally. The session will then focus on new scales developed in the study that can be used to screen patients today. Next the session will cover insights learned from speech and voice data captured. After a panel discussion led by lived experience leaders in the study there will be time for audience questions.
Format
Recorded webinar, non-interactive, self-paced distance learning activity.
This presentation was recorded at the 2025 American Psychiatric Association Annual Meeting.
Learning Objectives
- Understand the clinical high risk for psychosis state and the current understanding of how to assess risk for developing psychosis
- Apply early findings from AMP-SCZ to better understand your patient’s risk of conversion and other outcomes.
- Understand both local and national resources to help patients with clinical high risk for psychosis seek help and know where you can find answers to help care for these patients.
Target Audience
Medical Students, Residents/Fellows, Psychiatrists
Estimated Time to Complete
Estimated Duration: 1.0 hours
Begin Date: October 1, 2026
End Date: October 1, 2029
How to Earn Credit
Participants who wish to earn 1.5 AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Program Presenters
Program Planners
- Vishal Madaan, MD. Chief of Education and Deputy Medical Director, APA.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance